Organon (OGN) Operating Expenses (2020 - 2026)

Organon has reported Operating Expenses for 7 years, with the latest figure at $524.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 4.73% year-over-year to $524.0 million in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 8.33% decrease from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 3.45% from the prior year.
• Operating Expenses was $524.0 million for Q2 2026 at Organon, down from $548.0 million in the prior quarter.
• The five-year high for Operating Expenses was $675.0 million in Q3 2023, with the low at $467.0 million in Q1 2022.
• Average Operating Expenses over 5 years is $567.3 million, with a median of $559.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses increased 21.68% in 2022, then dropped 21.04% in 2024.
• Over 5 years, Operating Expenses stood at $629.0 million in 2022, then rose by 7.0% to $673.0 million in 2023, then slipped by 9.66% to $608.0 million in 2024, then retreated by 12.66% to $531.0 million in 2025, then retreated by 1.32% to $524.0 million in 2026.
• The last three Operating Expenses figures came in at $524.0 million (Q2 2026), $548.0 million (Q1 2026), and $531.0 million (Q4 2025), per Business Quant data.